SPECIAL ISSUE (2024)

Sustainable Legal Infrastructures: Comparative Responses Across Cultures and Systems

edited by Lucia Ruggeri, Lécia Vicente and Sara Zuccarino

 

EU Pharma Legislation Reform: Balancing Marketing
Authorization, Environmental Risk Assessment, and
IP Protection for Enhanced Innovation and Green
Transition

by Federica Laura Maggio

 

This paper examines the proposed reform of European pharmaceutical legislation, with particular focus on the regulation of marketing authorization and pre-authorization environmental risk assessment, as well as the issue of industrial property rights and the proposed relaxation of patent protection. This focus serves to highlight some critical issues related to the role of investments in supporting drug research and production and might be useful for analysing the public-private relationship in the production and commercialization of pharmaceuticals, especially regarding the related impact on attracting private capital for research, innovation, and the green transition of the sector.

DOI 10.23815/2421-2156.ITALJ           ISSN 2421-2156

 Read the full article